Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Urothelial Cancer

Clinical Trial at: Minnesota Oncology - Edina

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Gastric Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Phase 3, randomized, double-blind clinical study of pembrolizumab (MK-3475) plus chemotherapy versus placebo plus chemotherapy as first-line treatment in participants with HER2 negative, previously untreated, unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma (KEYNOTE-859)

  • Details

ClinicalTrials.gov ID: NCT03675737
Diagnosis Type: NA
USOR Number: 18097

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Phase III, Double-Blinded, Multicenter, Randomized Study Evaluating The Efficacy and Safety of Neo-adjuvant Treatment with Atezolizumab or Placebo in Combination with Platinum-Based Chemotherapy in Patients with Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (GO40241)

  • Details

ClinicalTrials.gov ID: NCT03456063
Diagnosis Type: NA
USOR Number: 17140

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Phase 2, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer (I3Y-MC-JPCM)

  • Details

ClinicalTrials.gov ID: NCT03706365
Diagnosis Type: NA
USOR Number: 18128

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Phase III, Double-Blinded, Multicenter, Randomized Study Evaluating The Efficacy and Safety of Neo-adjuvant Treatment with Atezolizumab or Placebo in Combination with Platinum-Based Chemotherapy in Patients with Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (GO40241)

  • Details

ClinicalTrials.gov ID: NCT03456063
Diagnosis Type: NSCLC
USOR Number: 17140

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Edina

Brigatinib-3001- A Phase 3 Randomized Open-label Study of Brigatinib (ALUNBRIG™) Versus Alectinib (ALECENSA®) in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer Patients Who Have Progressed on Crizotinib (XALKORI®)

  • Details

ClinicalTrials.gov ID: NCT03596866
Diagnosis Type: NA
USOR Number: 18129

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Minnesota Oncology - Edina

3000-03-005/ENGOT-OV44 : A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERAPY WITH TSR-042 AND NIRAPARIB VERSUS STANDARD OF CARE PLATINUM-BASED THERAPY AS FIRST-LINE TREATMENT OF STAGE III OR IV NONMUCINOUS EPITHELIAL OVARIAN CANCER

  • Details

ClinicalTrials.gov ID: NCT03602859
Diagnosis Type: NA
USOR Number: 17218

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Fallopian Tube Cancer

Clinical Trial at: Minnesota Oncology - Edina

3000-03-005/ENGOT-OV44 : A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERAPY WITH TSR-042 AND NIRAPARIB VERSUS STANDARD OF CARE PLATINUM-BASED THERAPY AS FIRST-LINE TREATMENT OF STAGE III OR IV NONMUCINOUS EPITHELIAL OVARIAN CANCER

  • Details

ClinicalTrials.gov ID: NCT03602859
Diagnosis Type: NA
USOR Number: 17218

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Rectal Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Phase 2 Study of INCMGA00012 in Participants With Squamous Carcinoma of the Anal Canal Who Have Progressed Following Platinum-Based Chemotherapy (POD1UM-202)

  • Details

ClinicalTrials.gov ID: NCT03597295
Diagnosis Type: NA
USOR Number: 18134

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Minnesota Oncology - Edina

3000-03-005/ENGOT-OV44 : A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERAPY WITH TSR-042 AND NIRAPARIB VERSUS STANDARD OF CARE PLATINUM-BASED THERAPY AS FIRST-LINE TREATMENT OF STAGE III OR IV NONMUCINOUS EPITHELIAL OVARIAN CANCER

  • Details

ClinicalTrials.gov ID: NCT03602859
Diagnosis Type: NA
USOR Number: 17218

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Minnesota Oncology - Edina

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Myelofibrosis

Clinical Trial at: Minnesota Oncology - Edina

INCB 39110-209, An Open-Label Phase 2 Study of Itacitinib (INCB039110) in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Subjects With Myelofibrosis

  • Details

ClinicalTrials.gov ID: NCT03144687
Diagnosis Type: NA
USOR Number: 17085

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Minnesota Oncology - Edina

TRITON2: A Multicenter, Open-label Phase 2 Study of Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency - CO-338-052

  • Details

ClinicalTrials.gov ID: NCT02952534
Diagnosis Type: NA
USOR Number: 16237

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Minnesota Oncology - Edina

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: NA
USOR Number: 16238

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Edina

CA209-817: A Phase IIIb/IV Safety and Efficacy Trial of Flat Dose Nivolumab in Combination with Ipilimumab in Participants with Non-Small Cell Lung Cancer

  • Details

ClinicalTrials.gov ID: NCT02869789
Diagnosis Type: NSCLC
USOR Number: 16156

  • Practice Details

6545 France Avenue, Suite 210
Edina, Minnesota 55435
552.27 mi. away
P: (952) 928-2900

More Details View Practice Page

Solid Tumors

Clinical Trial at: Minnesota Oncology - Minneapolis

(INCB 54828-207) A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

  • Details

ClinicalTrials.gov ID: NCT03822117
Diagnosis Type: NA
USOR Number: 19079

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Leukemia

Clinical Trial at: Minnesota Oncology - Minneapolis

A Phase 3b, Single-Arm, Multicenter Open-Label Study of Venetoclax in Combination with Azacitidine or Decitabine in an Outpatient Setting in AML Patients Ineligible for Intensive Chemotherapy (M19-072)

  • Details

ClinicalTrials.gov ID: NCT03941964
Diagnosis Type: NA
USOR Number: 18168

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

516-005: A Randomized Phase 3 Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with Disease Progression On or After Platinum-Based Chemotherapy in Combination with Checkpoint Inhibitor Therapy

  • Details

ClinicalTrials.gov ID: NCT03906071
Diagnosis Type: NA
USOR Number: 19018

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

A Randomized, Double-Blind, Phase 3 Study of Pemetrexed + Platinum Chemotherapy with or without Pembrolizumab (MK-3475) in TKI-resistant EGFR-mutated Tumors in Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) Participants (KEYNOTE-789; MK-3475-789)

  • Details

ClinicalTrials.gov ID: NCT03515837
Diagnosis Type: NA
USOR Number: 19020

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Lymphomas

Clinical Trial at: Minnesota Oncology - Minneapolis

A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) and CD30-expressing peripheral T-cell lymphoma (PTCL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Pages